PIK3CA
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Also known as: PI3K, PK3CA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P42336
- Gene
- PIK3CA
- Ensembl
- ENSG00000121879
- Chromosome
- 3
- Canonical length
- 1068 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Microtubules,Primary cilium,Mitochondria,Cytosol
OverviewNCBI Gene
Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
Canonical amino-acid sequenceUniProt
1068 residues, UniProt reviewed canonical sequence.
>P42336|PIK3CA
1 MPPRPSSGEL WGIHLMPPRI LVECLLPNGM IVTLECLREA TLITIKHELF KEARKYPLHQ
61 LLQDESSYIF VSVTQEAERE EFFDETRRLC DLRLFQPFLK VIEPVGNREE KILNREIGFA
121 IGMPVCEFDM VKDPEVQDFR RNILNVCKEA VDLRDLNSPH SRAMYVYPPN VESSPELPKH
181 IYNKLDKGQI IVVIWVIVSP NNDKQKYTLK INHDCVPEQV IAEAIRKKTR SMLLSSEQLK
241 LCVLEYQGKY ILKVCGCDEY FLEKYPLSQY KYIRSCIMLG RMPNLMLMAK ESLYSQLPMD
301 CFTMPSYSRR ISTATPYMNG ETSTKSLWVI NSALRIKILC ATYVNVNIRD IDKIYVRTGI
361 YHGGEPLCDN VNTQRVPCSN PRWNEWLNYD IYIPDLPRAA RLCLSICSVK GRKGAKEEHC
421 PLAWGNINLF DYTDTLVSGK MALNLWPVPH GLEDLLNPIG VTGSNPNKET PCLELEFDWF
481 SSVVKFPDMS VIEEHANWSV SREAGFSYSH AGLSNRLARD NELRENDKEQ LKAISTRDPL
541 SEITEQEKDF LWSHRHYCVT IPEILPKLLL SVKWNSRDEV AQMYCLVKDW PPIKPEQAME
601 LLDCNYPDPM VRGFAVRCLE KYLTDDKLSQ YLIQLVQVLK YEQYLDNLLV RFLLKKALTN
661 QRIGHFFFWH LKSEMHNKTV SQRFGLLLES YCRACGMYLK HLNRQVEAME KLINLTDILK
721 QEKKDETQKV QMKFLVEQMR RPDFMDALQG FLSPLNPAHQ LGNLRLEECR IMSSAKRPLW
781 LNWENPDIMS ELLFQNNEII FKNGDDLRQD MLTLQIIRIM ENIWQNQGLD LRMLPYGCLS
841 IGDCVGLIEV VRNSHTIMQI QCKGGLKGAL QFNSHTLHQW LKDKNKGEIY DAAIDLFTRS
901 CAGYCVATFI LGIGDRHNSN IMVKDDGQLF HIDFGHFLDH KKKKFGYKRE RVPFVLTQDF
961 LIVISKGAQE CTKTREFERF QEMCYKAYLA IRQHANLFIN LFSMMLGSGM PELQSFDDIA
1021 YIRKTLALDK TEQEALEYFM KQMNDAHHGG WTTKMDWIFH TIKQHALNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIK3CA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 14 nTPM
- thymus: 13 nTPM
- tongue: 12 nTPM
- bone marrow: 12 nTPM
- retina: 12 nTPM
- parathyroid gland: 11 nTPM
Single-cell type
- neutrophils: 385 nCPM
- neutrophil progenitors: 228 nCPM
- mast cells: 204 nCPM
- adipocytes: 172 nCPM
- sertoli cells: 163 nCPM
- adrenal cortex cells: 147 nCPM
Immune cell
- neutrophil: 2.2 nTPM
- naive B-cell: 1.6 nTPM
- memory B-cell: 1.5 nTPM
- basophil: 1.3 nTPM
- classical monocyte: 1.3 nTPM
- gdT-cell: 1.2 nTPM
Brain region
- cerebellum: 33 nTPM
- cerebral cortex: 29 nTPM
- white matter: 25 nTPM
- pons: 23 nTPM
- medulla oblongata: 22 nTPM
- midbrain: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIK3CA.
Disease | AllUniProt
Conditions PIK3CA is implicated in, by any mechanism.
- Colorectal cancer (CRC) MIM:114500
- Breast cancer (BC) MIM:114480
- Ovarian cancer (OC) MIM:167000
- Hepatocellular carcinoma (HCC) MIM:114550
- Keratosis, seborrheic (KERSEB) MIM:182000
- Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) MIM:602501
- Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) MIM:612918
- Cowden syndrome 5 (CWS5) MIM:615108
- CLAPO syndrome (CLAPO) MIM:613089
- Macrodactyly (MADAC) MIM:155500
- Cerebral cavernous malformations 4 (CCM4) MIM:619538
- Hemifacial myohyperplasia (HFMH) MIM:606773
Disease | GeneticClinVar
112 pathogenic / likely-pathogenic of 1,601 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- PIK3CA related overgrowth syndrome
- Megalencephaly-capillary malformation-polymicrogyria syndrome
- Neoplasm
- Cowden syndrome
- PIK3CA-related disorder
Disease | ImmuneIEDB
Conditions an epitope on PIK3CA was assayed in.
- breast cancer T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.12
- gnomAD pLI
- 1
- gnomAD missense Z
- 5.6
- DepMap mean gene effect
- -0.49
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- adipose tissue development
- angiogenesis
- anoikis
- autosome genomic imprinting
- cardiac muscle cell contraction
- cardiac muscle contraction
- cell migration
- cellular response to glucose stimulus
- cellular response to hydrostatic pressure
- cellular response to insulin stimulus
- endothelial cell migration
- energy homeostasis
- epidermal growth factor receptor signaling pathway
- glucose metabolic process
- insulin receptor signaling pathway
- insulin-like growth factor receptor signaling pathway
- liver development
- negative regulation of actin filament depolymerization
- negative regulation of anoikis
- negative regulation of fibroblast apoptotic process
- negative regulation of gene expression
- negative regulation of macroautophagy
- negative regulation of neuron apoptotic process
- phagocytosis
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- phosphatidylinositol phosphate biosynthetic process
- phosphatidylinositol-3-phosphate biosynthetic process
- phosphatidylinositol-mediated signaling
- platelet activation
- positive regulation of lamellipodium assembly
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of protein localization to membrane
- positive regulation of smooth muscle cell proliferation
- positive regulation of TOR signaling
- regulation of actin filament organization
- regulation of cellular respiration
- regulation of multicellular organism growth
- relaxation of cardiac muscle
- response to activity
- response to dexamethasone
- response to L-leucine
- response to muscle stretch
- T cell receptor signaling pathway
- TORC2 signaling
- vascular endothelial growth factor signaling pathway
- vasculature development
- response to butyrate
- response to muscle inactivity
Molecular functions
- 1-phosphatidylinositol-3-kinase activity
- 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity
- 1-phosphatidylinositol-4-phosphate 3-kinase activity
- ATP binding
- insulin receptor substrate binding
- protein kinase activator activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain
- Phosphatidylinositol 3-/4-kinase, catalytic domain
- Phosphoinositide 3-kinase, accessory (PIK) domain
- C2 phosphatidylinositol 3-kinase-type domain
- Phosphatidylinositol 3-kinase, adaptor-binding domain
- Protein kinase-like domain superfamily
- Phosphatidylinositol 3-/4-kinase
- Armadillo-type fold
- Phosphatidylinositol 3-/4-kinase, conserved site
- Ubiquitin-like domain superfamily
- C2 domain superfamily
- Phosphatidylinositol 3-/4-kinase, catalytic domain superfamily
- Phosphoinositide 3-kinase, accessory (PIK) domain superfamily
- Phosphatidylinositol 3- and 4-kinase
- Phosphoinositide 3-kinase family, accessory domain (PIK domain)
- Phosphoinositide 3-kinase C2
- PI3-kinase family, ras-binding domain
- PI3-kinase family, p85-binding domain
- Phosphatidylinositol 3-kinase alpha, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PIK3CA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIK3CA as an antibody target. Whether an autoantibody or antibody against PIK3CA could matter depends on whether native PIK3CA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIK3CA is annotated at the cell surface, where native PIK3CA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PIK3CA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...